Comparable stake leader
David Platt
SEC ownership of BIOXYTRAN, INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001445815.
Disclosed value leader
David Platt
Comparable rows
0/8
Latest evidence
14 Nov 2025
- Public ticker
- BIXT on OTC
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
David Platt
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
14 Nov 2025
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001445815
- Issuer location
- Needham, MA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of BIOXYTRAN, INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
David Platt
Disclosed value leader
David Platt
Comparable rows
0/8
Latest evidence
14 Nov 2025
3/4/5
Highest disclosed value: $12,882,399
8 rows are not safely comparable across share classes.
Quick read
David Platt has the largest disclosed position value at $12.88M.
0 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens David Platt's linked filing trail.
Disclosed position value
Top 5
David Platt
$12.88M
Michael Sheikh
$4.48M
Binder Offer
$1.72M
Ola Soderquist
$69.9K
Alan M. Hoberman
$145.7K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| David Platt |
3/4/5
CEO, Director, 10%+ Owner
|
— |
$12,882,399
|
— | 25 Oct 2024 |
| Michael Sheikh |
3/4/5
CCO, 10%+ Owner
|
—
class O/S missing
|
$4,477,022
8,214,720 shares
|
— | 25 Oct 2024 |
| Binder Offer |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$1,721,400
8,919,169 shares
|
— | 31 Dec 2021 |
| Ola Soderquist |
3/4/5
CFO, 10%+ Owner
|
—
mixed-class rows
|
$69,882
14,376,456 shares
mixed-class rows
|
— | 25 Oct 2024 |
| Alan M. Hoberman |
3/4/5
Director
|
—
mixed-class rows
|
$145,672
626,207 shares
mixed-class rows
|
— | 12 Aug 2025 |
| Dale H. Conaway |
3/4/5
Director
|
—
class O/S missing
|
$132,711
379,177 shares
|
— | 12 Aug 2025 |
| Anders Utter |
3/4/5
Director
|
—
class O/S missing
|
$130,402
372,580 shares
|
— | 14 Nov 2025 |
| Radka Milanova |
3/4/5
Director
|
—
class O/S missing
|
$71,290
203,688 shares
|
— | 12 Aug 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 04 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-9 of 9 reporting-owner rows connected to BIOXYTRAN, INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
9
Largest Forms 3/4/5 holder
David Platt
Net 12M change
$0
Latest report
14 Nov 2025
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| David Platt | CEO, Director, 10%+ Owner | $12,882,399 | Mixed | 25 Oct 2024 | ||
| Michael Sheikh | CCO, 10%+ Owner | $4,477,022 | Mixed | 25 Oct 2024 | ||
| Binder Offer | 10%+ Owner | $1,721,400 | Mixed | 31 Dec 2021 | ||
| Alan M. Hoberman | Director | $145,672 | Mixed | 12 Aug 2025 | ||
| Dale H. Conaway | Director | $132,711 | Mixed | 12 Aug 2025 | ||
| Anders Utter | Director | $130,402 | Mixed | 14 Nov 2025 | ||
| Radka Milanova | Director | $71,290 | Mixed | 12 Aug 2025 | ||
| Ola Soderquist | CFO, 10%+ Owner | $69,882 | Mixed | 25 Oct 2024 | ||
| Hana Chen-Walden | Director | Mixed | 31 Dec 2023 |
Recent insider transactions for BIOXYTRAN, INC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Alan M. Hoberman | BIXT | common | Purchase | 210,000 | 210,000 | 18 Nov 2025 | Direct | |||
| Alan M. Hoberman | BIXT | preferred | Award | 10.2% | 38,588 | 416,207 | 14 Nov 2025 | Direct | ||
| Radka Milanova | BIXT | preferred | Award | 23.4% | 38,588 | 203,688 | 14 Nov 2025 | Direct | ||
| Dale H. Conaway | BIXT | preferred | Award | 11.3% | 38,588 | 379,177 | 14 Nov 2025 | Direct | ||
| Anders Utter | BIXT | preferred | Award | 11.6% | 38,588 | 372,580 | 14 Nov 2025 | Direct | ||
| Alan M. Hoberman | BIXT | preferred | Award | 2.84% | 10,417 | 377,619 | 12 Aug 2025 | Direct | ||
| Radka Milanova | BIXT | preferred | Award | 6.73% | 10,417 | 165,100 | 12 Aug 2025 | Direct | ||
| Dale H. Conaway | BIXT | preferred | Award | 3.16% | 10,417 | 340,589 | 12 Aug 2025 | Direct |
* marks a reported price that did not pass the local price check.